Nativis has developed a molecular biology approach to treating glioblastoma that avoids surgery, chemo and radiation. Our animation shows the technology breakthrough and the MOA. With checkpoint inhibition turned off, T-cells aggressively attack glioblastoma cells in situ.
Keywords: Models, Microscopy, Editorial, Patient Education, Mobile, Research, Biotechnology, Cell biology / Histology, Neuroscience, Oncology
© David Bolinsky